Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles
Authors
Keywords
Pregnane X Receptor, Antagonist, High-throughput screening, Pimecrolimus, Pazopanib
Journal
ARCHIVES OF TOXICOLOGY
Volume 92, Issue 4, Pages 1435-1451
Publisher
Springer Nature
Online
2018-01-22
DOI
10.1007/s00204-018-2165-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SPA70 is a potent antagonist of human pregnane X receptor
- (2017) Wenwei Lin et al. Nature Communications
- Small-molecule modulators of PXR and CAR
- (2016) Sergio C. Chai et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes
- (2016) Benjamin A. Kandel et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Non-canonical modulators of nuclear receptors
- (2016) Colin M. Tice et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Skin response to a carcinogen involves the xenobiotic receptor pregnane X receptor
- (2015) Andreas Elentner et al. EXPERIMENTAL DERMATOLOGY
- Screening of a chemical library reveals novel PXR-activating pharmacologic compounds
- (2015) Marcin Ratajewski et al. TOXICOLOGY LETTERS
- Carboxymefloquine, the Major Metabolite of the Antimalarial Drug Mefloquine, Induces Drug-Metabolizing Enzyme and Transporter Expression by Activation of Pregnane X Receptor
- (2014) Rita Piedade et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms
- (2014) Andreas Bitter et al. ARCHIVES OF TOXICOLOGY
- Role of pregnane X receptor in chemotherapeutic treatment
- (2014) Wei Zhuo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancer
- (2013) Yanli Deng et al. XENOBIOTICA
- Isolation of Human Hepatocytes by a Two-step Collagenase Perfusion Procedure
- (2013) Serene M.L. Lee et al. Jove-Journal of Visualized Experiments
- Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters
- (2012) Yakun Chen et al. BIOCHEMICAL PHARMACOLOGY
- Sesamin: A Naturally Occurring Lignan Inhibits CYP3A4 by Antagonizing the Pregnane X Receptor Activation
- (2012) Yun-Ping Lim et al. Evidence-based Complementary and Alternative Medicine
- Role of CAR and PXR in xenobiotic sensing and metabolism
- (2012) Yue-Ming Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Fucoxanthin Attenuates Rifampin-Induced Cytochrome P450 3A4 (CYP3A4) and Multiple Drug Resistance 1 (MDR1) Gene Expression Through Pregnane X Receptor (PXR)-Mediated Pathways in Human Hepatoma HepG2 and Colon Adenocarcinoma LS174T Cells
- (2012) Cheng-Ling Liu et al. Marine Drugs
- Concise Drug Review: Pazopanib and Axitinib
- (2012) R. M. J. M. van Geel et al. ONCOLOGIST
- Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma
- (2011) Mathieu Boulin et al. ANTI-CANCER DRUGS
- Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene
- (2011) Lucie Krausova et al. BIOCHEMICAL PHARMACOLOGY
- Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor
- (2011) E Hoffart et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice
- (2011) Hongwei Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- In Vivo and In Vitro Characterization of a First-in-Class Novel Azole Analog That Targets Pregnane X Receptor Activation
- (2011) M. Venkatesh et al. MOLECULAR PHARMACOLOGY
- Overcoming drug resistance by regulating nuclear receptors
- (2010) Taosheng Chen ADVANCED DRUG DELIVERY REVIEWS
- Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
- (2010) Antonia H. Tolson et al. ADVANCED DRUG DELIVERY REVIEWS
- Camptothecin Attenuates Cytochrome P450 3A4 Induction by Blocking the Activation of Human Pregnane X Receptor
- (2010) Y. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo
- (2009) S Riedmaier et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Minireview: Not Picking Pockets: Nuclear Receptor Alternate-Site Modulators (NRAMs)
- (2009) Terry W. Moore et al. MOLECULAR ENDOCRINOLOGY
- Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR)
- (2008) Bhaskar C. Das et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Computational Discovery of Novel Low Micromolar Human Pregnane X Receptor Antagonists
- (2008) S. Ekins et al. MOLECULAR PHARMACOLOGY
- The Phytoestrogen Coumestrol Is a Naturally Occurring Antagonist of the Human Pregnane X Receptor
- (2007) Hongwei Wang et al. MOLECULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search